AgResearch, the largest of New Zealand's crown research institutes, has formed a new company with San Diego venture capital firm Finistere Partners, to commercialise its plant genome technology in the US.

Industrial biotech will eclipse its so-called 'red' and 'green' cousins, as industries are forced to adapt to environmental pressure, the head of global biosciences at the giant Proctor & Gamble corporation has predicted.

Western Australia's new premier, Alan Carpenter, has created a portfolio for science and innovation.

Biotechnology has provided a solution to the problem of how to get science to the market without compromising research, writes editor-in-chief Iain Scott.

Kiran Mazumdar-Shaw told AusBiotech 2005 about opportunities for Australian biotech to work with India.

US venture capitalist Osagie Imasogie told AusBiotech 2005 that biotech companies need to get aggressive when it comes to finding opportunities.

Pfizer's Peter Corr told the AusBiotech 2005 conference that big pharma and biotech are part of a delicate ecosystem -- and both have key roles to play.

In many places in the world, 'biotechnology' only means agricultural biotech. The same can't be said in Australia, where GM technology is a dirty word. But could economics and technology force Australia to change its views on biotech crops to keep up with the rest of the world?

AusBiotech and its South Korean equivalent, the Bioindustry Association of Korea (BAK), have signed an agreement that they hope will lead to a stronger relationship between the two countries' biotech industries.

If your brain disengages when you read the word 'ethics', perhaps you'd better switch it on again, writes Iain Scott -- there's a lot you haven't heard on the subject.

The scene: biotechnology is the quintessential knowledge-based industry. But most of its advances have come from advancements in information technology, and how they are applied to genetic processes. Could this be a model for the biotechnology industry in NSW in 2020?